Nevertheless, when carefully evaluating and excluding potential confounders of elevated NfL levels, i.e., brain surgery, trauma or stroke, our study supports NfL as biomarker to identify patients with an underlying rapidly progressive neuropathology, such as MSA. This evidence concerns the gene NEFL and Stroke.